Emergence, Spread, and Extinction of Pathogenic Bacterial Clones

Lesley McGee; Fred C. Tenover; Bernard Beall; Keith P. Klugman

doi:10.1128/9781555815639.ch17

Chapter 17 : Emergence, Spread, and Extinction of Pathogenic Bacterial Clones

Authors: Lesley McGee¹, Fred C. Tenover², Bernard Beall³, Keith P. Klugman⁴

VIEW AFFILIATIONS HIDE AFFILIATIONS

Affiliations: 1: Rollins School of Public Health, Emory University, Atlanta, GA 30322; 2: Centers for Disease Control and Prevention, Atlanta, GA 30333; 3: Centers for Disease Control and Prevention, Atlanta, GA 30333; 4: Rollins School of Public Health, Emory University, Atlanta, GA 30322

Content Type: Monograph

Publication Year: 2008

Category: Fungi and Fungal Pathogenesis; Bacterial Pathogenesis

Book DOI: 10.1128/9781555815639

Chapter DOI: 10.1128/9781555815639.ch17

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter

Preview this chapter:

Emergence, Spread, and Extinction of Pathogenic Bacterial Clones, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555815639/9781555814144_Chap17-1.gif /docserver/preview/fulltext/10.1128/9781555815639/9781555814144_Chap17-2.gif

Abstract:

The tremendous genetic diversity observed among pathogenic bacteria mirrors their different lifestyles and physiological versatility; their evolution has enabled them to adapt to specific niches and growth conditions. A remarkable aspect of the major gram-positive community-acquired pathogens infecting humans is the extent of their clonality. A number of factors may influence the emergence, spread, and extinction of clones. These are discussed sequentially for Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae, and the common themes and differences between these organisms are explored. A series of methicillin-susceptible S. aureus isolates of phage type 80/81 isolated between 1962 and 1998, most of which were multilocus sequence type (ST) 30, have been shown to harbor the genes encoding Panton-Valentine Leucocidin (PVL), a common virulence factor among many isolates of contemporary community-associated methicillin-resistant S. aureus (CA-MRSA) strains. Infectious disease epidemiology is characterized by patterns of emergence, spread, and evolution of strains, with phases of reduction and apparent extinction or stabilization of genetic types, and the emergence of new pathogenic or antimicrobial-resistant clones. A major determinant in the stability of bacterial clones is the relative impact of point mutations, DNA rearrangements and horizontal gene transfer, and bacteriophage acquisition, although other factors are undoubtedly important. An expansion in the implementation of sequencing methodologies and clustering algorithms to examine clonal emergence and spread will be important for our continued understanding of how bacteria evolve to become virulent and the response of bacterial populations to antibiotics and vaccines.

Citation: McGee L, Tenover F, Beall B, Klugman K. 2008. Emergence, Spread, and Extinction of Pathogenic Bacterial Clones, p 185-195. In Baquero F, Nombela C, Cassell G, Gutiérrez-Fuentes J (ed), Evolutionary Biology of Bacterial and Fungal Pathogens. ASM Press, Washington, DC. doi: 10.1128/9781555815639.ch17

Highlighted Text: Show | Hide

Full text loading...

References

/content/book/10.1128/9781555815639.ch17

1. Asheshov, E. H., and, J. E. Rippon. 1959. Changes in typing patterns of phage-type 80 staphylococci. J. Gen. Microbiol. 20:634–643.

2. Baba, T.,, F. Takeuchi,, M. Kuroda,, H. Yuzawa,, K. Aoki,, A. Oguchi,, Y. Nagai,, N. Iwama,, K. Asnao,, T. Naimi,, H. Kuroda,, L. Cui,, K. Yamamoto, and, K. Hiramasu. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359:1819–1827.

3. Barocchi, M. A.,, J. Ries,, X. Zogaj,, C. Hemsley,, B. Albiger,, A. Kanth,, S. Dahlberg,, J. Fernebro,, M. Moschioni,, V. Masignani,, K. Hultenby,, A. R. Taddei,, K. Beiter,, F. Wartha,, A. von Euler,, A. Covacci,, D. W. Holden,, S. Normark,, R. Rappuoli, and, B. Henriques-Normark. 2006. A pneumococcal pilus influences virulence and host inflammatory responses. Proc. Natl. Acad. Sci. USA 103:2857–2862.

4. Broudy, T. B., and, V. A. Fischetti. 2003. In vivo lysogenic conversion of Tox(−) Streptococcus pyogenes to Tox(+) with lysogenic streptococci or free phage. Infect. Immun. 71:3782–3786.

5. Brueggemann, A. B.,, D. T. Griffiths,, E. Meats,, T. Peto,, D. W. Crook, and, B. G. Spratt. 2004. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotypeand clone-specific differences in invasive disease potential. J. Infect. Dis. 189:785–796.

6. Bruggemann, A. B., and, B. G. Spratt. 2003. Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J. Clin. Microbiol. 41:4966–4970.

7. Buckingham, S. C.,, L. K. McDougal,, L. D. Cathey,, K. Comeaux,, A. S. Craig,, S. K. Fridkin, and, F. C. Tenover. 2004. Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children’s Hospital. Pediat. Infect. Dis. J. 23:619–624.

8. Bynoe, E. T.,, R. Elder, and, R. D. Comtois. 1956. Phage-typing and antibiotic-resistance of staphylococci isolated in a general hospital. Can. J. Microbiol. 2:346–358.

9. Centers for Disease Control and Prevention. 1999. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota. 1997–1999. Morb. Mortal. Wkly. Rep. 48:707–710.

10. Centers for Disease Control and Prevention. 2001. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison—Mississippi, 2000. Morb. Mortal. Wkly. Rep. 50:919–922.

11. Centers for Disease Control and Prevention. 2003a. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants—Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000–2003. Morb. Mortal. Wkly. Rep. 52:793–795.

12. Centers for Disease Control and Prevention. 2003b. Public Health Dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections—Los Angeles County, California, 2002–2003. Morb. Mortal. Wkly. Rep. 52:88–89.

13. Chavez-Bueno, S.,, B. Bozdogan,, K. Katz,, K. L. Bowlware,, N. Cushion,, D. Cavuoti,, N. Ahmad,, G. H. McCracken, Jr., and, P. C. Appelbaum. 2005. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob. Agents Chemother. 49:2283–2288.

14. Cleary, P. P.,, D. LaPenta,, R. Vessela,, H. Lam, and, D. Cue. 1998. A globally disseminated M1 subclone of group A streptococci differs from other subclones by 70 kilobases of prophage DNA and capacity for high-frequency intracellular invasion. Infect. Immun. 66:5592–5597.

15. Cleary, P. P.,, E. L. Kaplan,, J. P. Handley, et al. 1992. Clonal basis for resurgence of serious streptococcal disease in the 1980’s. Lancet 321:518–521.

16. Davis, J. P.,, P. J. Chesney,, P. J. Wand,, M. LaVenture, andthe Investigation and Laboratory Team. 1980. Toxic-shock syndrome. N. Engl. J. Med. 303:1429–1435.

17. Diep, B. A.,, S. R. Gill,, R. F. Chang,, T. H. Phan,, J. H. Chen,, M. G. Davidson,, F. Lin,, J. Lin,, H. A. Carleton,, E. F. Mongodin,, G. F. Sensabaugh, and, F. Perdreau-Remington. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet. 367:731–739.

18. Enright, M. C.,, D. Robinson,, G. Randle,, E. J. Feil,, H. Grundmann, and, B. G. Spratt. 2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA) Proc. Natl. Acad. Sci. USA 99:7689–7692.

19. Farrell, D. J.,, S. G. Jenkins,, S. D. Brown,, M. Patel,, B. S. Lavin, and, K. P. Klugman. 2005. Emergence and spread of Streptococcus pneumoniae with erm (B) and mef(A) resistance. Emerg. Infect. Dis. 11:851–858.

20. Feikin, D. R.,, K. P. Klugman,, R. R. Facklam,, E. R. Zell,, A. Schuchat, and, C. G. Whitney. 2005. Active Bacterial Core Surveillance/Emerging Infections Program Network. Increased prevalence of pediatric pneumococcal serotypes in elderly adults. Clin. Infect. Dis. 41:481–487.

21. Finland, M., and, M. W. Barnes. 1977. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City hospital during selected years between 1935 and 1974. J. Clin. Microbiol. 5:154–166.

22. Fridkin, S. K.,, J. C. Hageman,, M. Morrison,, L. T. Sanza,, K. Como-Sabetti,, J. A. Jernigan,, K. Harriman,, L. H. Harrison,, R. Lynfield, and, M. M. Farleyfor the Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. 2005. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352:1436–1444.

23. Gertz, R. E. Jr.,, M. C. McEllistrem,, D. J. Boxrud,, Z. Li,, V. Sakota,, T. A. Thompson,, R. R. Facklam,, J. M. Besser,, L. H. Harrison,, C. G. Whitney, and, B. Beall. 2003. Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J. Clin. Microbiol. 41:4194–4216.

24. Goshorn, S. C., and, P. M. Schlievert. 1989. Bacteriophage association of streptococcal pyrogenic exotoxin type C. J. Bacteriol. 171:3068–3073.

25. Griffiths, F. 1928. The significance of pneumococcal types. J. Hyg. 27:113–159.

26. Groom, A. V.,, D. H. Wolsey,, T. S. Naimi,, K. Smith,, S. Johnson,, D. Boxrud,, K. A. Moore, and, J. E. Cheek. 2001. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. J. Amer. Med. Assoc. 286:1201–1205.

27. Hanage, W. P.,, T. H. Kaijalainen,, R. K. Syrjänen,, K. Auranen,, M. Lenonen,, P. H. Mäkelä, and, B. G. Spratt. 2005. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect. Immun. 73:431–435.

28. Hausdorff, W. P.,, J. Bryant,, P. R. Paradiso, and, G. R. Siber. 2000. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use. Part I. Clin. Infect. Dis. 30:100–121.

29. Hedlund, J.,, S. B. Sevnson,, M. Kalin,, J. Henrichsen,, B. Olsson-Liljequist,, G. Mollerberg, and, G. Kallenius. 1995. Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden. Clin. Infect. Dis. 21:948–953.

30. Henriques, N. B.,, M. Katlin,, A. Ortqvist,, T. Akerlund,, B. O. Liljequist,, J. Hedlund,, S. B. Svenson,, J. Zhou,, B. G. Spratt,, S. Normark, and, G. Kallenius. 2001. Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J. Infect. Dis. 184:861–869.

31. Herold, B. C.,, L. C. Immergluck,, M. C. Maranan,, D. S. Lauderdale,, R. E. Gaskin, and, S. Boyle-Vavra. 1998. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279:593–598.

32. Hidron, A. I.,, E. V. Kourbatova,, J. S. Halvosa,, B. J. Terrell,, L. K. McDougal,, F. C. Tenover,, H. M. Blumberg, and, M. D. King. 2005. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin. Infect. Dis. 41:159–166.

33. Igwe, E. I.,, P. L. Shewmaker,, R. R. Facklam,, M. M. Farley,, C. van Beneden, and, B. Beall B. 2003. Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol. Lett. 229:259–264.

34. Kalia, A., and, D. E. Bessen. 2003. Presence of streptococcal pyrogenic exotoxin A and C genes in human isolates of group G streptococci. FEMS Microbiol. Lett. 219:291–295.

35. Kaplan, S. L.,, K. G. Hulten,, B. E. Gonzalez,, W. A. Hammerman,, L. Lamberte,, J. Versalovic, and, E. O. Mason. 2005. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin. Infect. Dis. 40:1785–1791.

36. Kazakova, S. V.,, J. C. Hageman,, M. K. Matava,, A. Srinivasan,, L. Phelan,, B. Garfinkel,, T. Boo,, S. McAllister,, J. Anderson,, B. Jensen,, D. Dodson,, D. Lonsway,, L. McDougal,, M. Arduino,, V. J. Fraser,, G. Killgore,, F. C. Tenover,, S. Cody, and, D. B. Jernigan. 2005. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352:468–475.

37. King, M. D.,, B. J. Humphrey,, Y. F. Wang,, E. V. Kourbatova,, S. M. Ray, and, H. M. Blumberg. 2006. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann. Intern. Med. 144:309–317.

38. Ko, K. S., and, J. H. Song. 2004. Evolution of erythromycin-resistant Streptococcus pneumoniae from Asian countries that contains erm (B) and mef(A) genes. J. Infect. Dis. 190:739–747.

39. Li, Z.,, V. Sakota,, D. Jackson,, A. R. Franklin, and, B. Beall. 2003. The array of M protein gene subtypes in 1061 recent invasive group A streptococcal isolates recovered from the Active Bacterial Core Surveillance. J. Infect. Dis. 188:1587–1592.

40. Lina, G.,, Y. Piemont,, F. Godail-Gamot,, M. Bes,, M. O. Peter,, V. Gauduchon,, F. Vandenesch, and, J. Etienne. 1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29:1128–1132.

41. Lukomski, S.,, K. Nakashima,, I. Abdi,, V. J. Cipriano,, R. M. Ireland,, S. D. Reid,, G. G. Adams, and, J. M. Musser. 2000. Identification and characterization of the scl gene encoding a group A Streptococcus extracellular protein virulence factor with similarity to human collagen. Infect. Immun. 68:6542–6553.

42. Ma, X. X.,, A. Galiana,, W. Pedreira,, M. Mowszowicz,, I. Christophersen,, S. Machiavello,, L. Lope,, S. Benaderet,, F. Buela,, W. Vicentino,, M. Albini,, O. Bertaux,, I. Constenla,, H. Bagnulo,, L. Llosa,, T. Ito, and, K. Hiramatsu. 2005. Community-acquired methicillin-resistant Staphylococcus aureus, Uruguay. Emerg Infect Dis. 11:9736–9745.

43. McDougal, L. K.,, C. D. Steward,, G. E. Killgore,, J. M. Chaitram,, S. K. McAllister, and, F. C. Tenover. 2003. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:5113–5120.

44. McGee, L.,, L. McDougal,, J. Zhou,, B. G. Spratt,, F. C. Tenover,, R. George,, R. Hakenbeck,, W. Hryniewicz,, J. C. Lefevre,, A. Tomasz, and, K. P. Klugman. 2001. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J. Clin. Microbiol. 39:2565–2571.

45. McGregor, K. F.,, B. G. Spratt,, A. Kalia,, A. Bennett,, N. Bilek,, B. Beall, and, D. E. Bessen. 2004. Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. J. Bacteriol. 186:4285–4294.

46. Munoz, R.,, T. J. Coffey,, M. Daniels,, C. G. Dowson,, G. Laible,, J. Casal,, R. Hakenbeck,, M. Jacobs,, J. M. Musser,, B. G. Spratt, et al. 1999. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J. Infect. Dis. 164:302–306.

47. Musser, J. M.,, P. M. Schlievert,, A. W. Chow,, P. Ewan,, B. N. Kreiswirth,, V. T. Rosdahl,, A. S. Naidu,, W. Witte, and, R. K. Selander. 1990. A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc. Natl. Acad. Sci. USA 87:225–229.

48. Nahmias, A. J.,, J. T. Godwin,, E. L. Updykes, and, W. A. Hopkins. 1960. Postsurgical staphylococcic infections. Outbreaks traced to an individual carrying phage strains 80/81 and 80/81/52/52A. JAMA 174:1269–1275.

49. Naimi, T. S.,, K. H. LeDell,, D. J. Boxrud,, A. V. Groom,, C. D. Steward,, S. K. Johnson,, J. M. Besser,, C. O’Blyle,, R. N. Danila,, J. E. Cheek,, M. T. Osterholm,, K. A. Moore, and, K. E. Smith. 2001. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996–1998. Clin. Infect. Dis. 33:990–996.

50. Naimi, T. S.,, K. H. LeDell,, K. Como-Sabetti,, S. M. Borchardt,, D. J. Boxrud,, J. Etienne,, S. K. Johnson,, F. Vandenesch,, S. Fridkin,, C. O’Boyle,, R. N. Danila, and, R. Lynfield. 2003. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:2976–2984.

51. O’Brien, K. L.,, B. Beall,, N. L. Barrett,, P. R. Cieslak,, A. Reingold,, M. M. Farley,, R. Danila,, E. R. Zell,, R. Facklam,, B. Schwartz, and, A. Schuchat. 2002. Epidemiology of invasive group A streptococcus disease in the United States, 1995–1999. Clin. Infect. Dis. 35:268–276.

52. Okuma, K.,, K. Iwakawa,, J. D. Turnidge,, W. B. Grubb,, J. M. Bell,, F. G. O’Brien,, G. W. Coombs,, J. W. Pearman,, F. C. Tenover,, M. Kapi,, C. Tiensasitorn,, T. Ito, and, K. Hiramatsu. 2002. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J. Clin. Microbiol. 40:4280–4294.

53. Orskov, F.,, I. Orskov,, D. J. Evans,, R. B. Sack, and, T. Wadstrom. 1976. Special Escherichia coli serotypes among enterotoxigenic strains from diarrhea in adults and children. Med. Microbiol. Immunol. 162:73–80.

54. Orskov, F., and, I. Orskov. 1983. Summary of a workshop on the clone concept in the epidemiology, taxonomy, and evolution of the Enterobacteriaceae and other bacteria. J. Infect. Dis. 148:346–357.

55. Örtqvist, A.,, J. Hedlund, and, M. Katlin. 2005. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. Semin. Respir. Crit. Care Med. 26:563–574.

56. Pai, R.,, R. E. Gertz,, C. G. Whitney, and, B. Beall. 2005a. Clonal association between Streptococcus pneumoniae serotype 23A, circulating within the United States, and an internationally dispersed clone of serotype 23F. J. Clin. Microbiol. 43:5440–5444.

57. Pai, R.,, M. R. Moore,, T. Pilishvili,, R. E. Gertz,, C. G. Whitney, and, B. Beall. 2005b. Active Bacterial Core Surveillance Team. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J. Infect. Dis. 192:1988–1995.

58. Porat, N.,, G. Barkai,, M. R. Jacobs,, R. Tefler, and, R. Dagan. 2004. Four-antibiotic resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel. J. Infect. Dis. 189:385–392.

59. Reinert, R. R.,, M. R. Jacobs,, P. C. Appelbaum,, S. Bajaksouzian,, S. Cordeiro,, M. van der Linden, and, A. Al-Lahham. 2005. Relationship between the original multiply resistant South African isolates of Streptococcus pneumoniae from 1977 to 1978 and contemporary international resistant clones. J. Clin. Microbiol. 43:6035–6041.

60. Roberts, J. C.,, R. L. Krueger,, K. K. Peak,, W. Veguilla,, A. C. Cannons,, P. T. Amuso, and, J. Cattani. 2006. Community-associated methicillin-resistant Staphylococcus aureus epidemic clone USA300 in isolates from Florida and Washington. J. Clin. Microbiol. 44:225–226.

61. Robinson, D. A.,, D. E. Briles,, M. J. Crain, and, S. K. Hollingshead. 2002. Evolution and virulence of serogroup 6 pneumococci on a global scale. J. Bacteriol. 184:6367–6375.

62. Robinson, D. A.,, A. M. Kearns,, A. Holmes,, D. Morrison,, H. Grundmann,, G. Edwards,, F. G. O’Brien,, F. C. Tenover,, L. K McDougal,, A. B. Monk, and, M. C. Enright. 2005. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired methicillin-resistant clone. Lancet 365:1256–1258.

63. Rountree, P. M., and, B. M. Freeman. 1955. Infections caused by a particular type of Staphylococcus aureus. Med. J. Aust. 2:157–161.

64. Saiman, L.,, M. O’Keefe,, P. L. Graham,, F. Wu,, B. Said-Salim,, B. Kreiswirth,, A. LaSala,, P. M. Schlievert, and, P. Della-Latta. 2003. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin. Infect. Dis. 37:1313–1319.

65. Sandgren, A.,, K. Sjöström,, B. Olsson-Liljequist,, B. Christennson,, A. Samuelsson,, G. Kronvall, and, B. H. Normark. 2004. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J. Infect. Dis. 189:785–796.

66. Schlievert, P. M.,, K. N. Shands,, B. B. Dan,, G. P. Schmid, and, R. D. Nishimura. 1981. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome. J. Infect. Dis. 143:509–516.

67. Schlievert, P. M.,, T. J. Tripp, and, M. L. Peterson. 2004. Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000–2003 surveillance period. J. Clin. Microbiol. 42:2875–2876.

68. Schrag, S. J.,, L. McGee,, C. G. Whitney,, B. Beall,, A. S. Craig,, M. E. Choate,, J. H. Jorgensen,, R. R. Facklam, and, K. P. Klugmanfor the Active Bacterial Core Surveillance Team. 2004. Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin. Antimicrob. Agents Chemother. 48:3016–3023.

69. Seybold, U.,, E. V. Kourbatova,, J. G. Johnson,, S. J. Halvosa,, Y. F. Wang,, M. D. King,, S. M. Ray, and, H. M. Blumberg. 2006. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin. Infect. Dis. 42:647–656.

70. Shands, K. N.,, G. P. Schmid,, B. B. Dan,, D. Blum,, R. J. Guidotti,, N. T. Hargrett,, R. L. Anderson,, D. L. Hill,, C. V. Broome,, J. D. Band, and, D. W. Fraser. 1980. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N. Engl. J. Med. 303:1436–1442.

71. Shukla, S. K.,, M. E. Stemper,, S. V. Ramaswamy,, J. M. Conradt,, R. Reich,, E. A. Graviss, and, K. D. Reed. 2004. Molecular characteristics of nosocomial and Native American community-associated methicillin-resistant Staphylococcus aureus clones from Rural Wisconsin. J. Clin. Microbiol. 42:3752–3757.

72. Shulman, S. T.,, G. Stollerman,, B. Beall,, J. B. Dale, and, R. R. Tanz. 2006. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin. Infect. Dis. 42:441–447.

73. Shulman, S. T.,, R. R. Tanz,, W. Kabat,, K. Kabat,, E. Cederlund,, D. Patel,, Z. Li,, V. Sakota,, J. B. Dale, and, B. Beall. 2004. Group A streptococcal pharyngitis serotype surveillance in North America, 2000–2002. Clin. Infect. Dis. 39:325–332.

74. Simon, H. J.,, S. J. Yaffe, and, L. Gluck. Effective control of staphylococcal outbreak in a nursery. N. Engl. J. Med. 265:1171–1176.

75. Smith, A. M., and, K. P. Klugman. 1997. Three predominant clones identified within penicillin-resistant South African isolates of Streptococcus pneumoniae. Microb. Drug Resist. 3:385–389.

76. Soares, S.,, K. G. Kristinsson,, J. M. Musser, and, A. Tomasz. 1993. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the later 1980s. J. Infect. Dis. 168:158–163.

77. Sumby, P.,, S. F. Porcella,, A. G. Madrigal,, K. D. Barbian,, K. Virtaneva,, S. M. Ricklefs,, D. E. Sturdevant,, M. R. Graham,, J. Vuopio-Varkila,, N. P. Hoe, and, J. M. Musser. 2005. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J. Infect. Dis. 192:771–825.

78. Taylor, J.,, B. W. Powell, and, J. Wright. 1949. Infantile diarrhea and vomiting: a clinical and bacteriological investigation. Br. Med. J. [Clin. Res.] 2:117–125.

79. Tenover, F. C.,, L. K. McDougal,, R. V. Goering,, G. Killgore,, S. Projan,, J. B. Patel, and, P. M. Dunman. 2006. Characterization of a widely disseminated strain of community-associated methicillin-resistant Staphylococcus aureus from the United States. J. Clin. Microbiol. 44:108–118.

80. Tietz, A.,, R. Frei, and, A. F. Widmer. 2005. Transatlantic spread of the USA300 clone of MRSA. N. Engl. J. Med. 353:532–533.

81. Todd, J.,, M. Fishaut,, F. Kapral, and, T. Welch. 1978. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 2:1116–1118.

82. Trzcińmski, K.,, C. M. Thompson, and, M. Lipsitch. 2004. Single-step capsule transformation and acquisition of penicillin resistance in Streptococcus pneumoniae. J. Bacteriol. 186:3447–3452.

83. Vela, M. C.,, N. Fonseca,, J. L. Di Fabio, and, E. Castaneda. 2001. Presence of international multiresistant clones of Streptococcus pneumoniae in Colombia. Microb. Drug. Resist. 7:153–164.

84. Zabriskie, J. 1964. The role of temperate bacteriophage in the production of erythrogenic toxin by Group A Streptococci. J. Exp. Med. 119:761–780.

85. Zinderman, C. E.,, B. Conner,, M. A. Malakooti,, J. E. LaMar,, A. Armstrong, and, B. K. Bohnker. 2004. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg. Infect. Dis. 10:941–944.